Test Summary Sheet for:

Purpose
Forensic Analysis; Exposure Monitoring/Abuse Monitoring. Over the last six years, NMS Labs has continually invested in research and intelligence gathering, then rapid test development and thorough validation to ensure we are offering testing for the most current synthetic cannabinoids in the rapidly changing designer drug/NPS arena. Our commitment to forensic defensibility for our tests means that compounds identified in this screening test will be confirmed by additional testing, included in the price of the test. Please contact NMS Labs for additional information
Method(s)
High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP)
Suggested CPT Code(s)
80307
New York State Approval Status

Approved

Turnaround Time

5 days (If Positive: 12 days)

Test Includes
1 AMB-FUBINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide AB-FUBINACA High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
2 4-cyano-CUMYL-BINACA 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
3 ADMB-FUBICA ADB-FUBICA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
4 ADMB-FUBINACA ADB-FUBINACA; N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
5 5-fluoro-QU-PINAC 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indazole-3-carboxylic acid; 5-fluoro NPB 22 High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
6 MMB-FUBICA methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
7 5-fluoro-MMB-PINACA 5-fluoro AMB; methyl ester; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.05 Synthetic Cannabinoid
8 4-fluoro-MDMB-BINACA 4-fluoro-MDMB-BUTINACA; methyl (S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
9 5-fluoro-MDMB-PICA methyl ester; N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
10 MMB-FUBINACA FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
11 CUMYL-THPINACA N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
12 MDMB-FUBICA methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
13 5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA 5F-ADB/5F-AEB; methyl ester/ ethyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)-L-valinate; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.2 Synthetic Cannabinoid
14 AMB-CHMINACA AB-CHMINACA; N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
15 MDMB-FUBINACA / EMB-FUBINACA 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate/ethyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
16 NA-FUBIM (1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone; FUB-JWH-018 High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.2 Synthetic Cannabinoid
17 5-fluoro-EDMB-PINACA ethyl (S)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
18 ADMB-CHMINACA ADB-CHMINACA; MAB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
19 MMB-CHMICA methyl (1-(cyclohexylmethyl)-1H-indole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
20 5-fluoro-NA-PIC naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; NM-2201 High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
21 MDMB-CHMICA methyl ester; N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
22 MMB-CHMINACA MA-CHMINACA; methyl (1-(cyclohexylmethyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.2 Synthetic Cannabinoid
23 NA-FUBIC 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 1-naphthalenyl ester; FDU-PB-22 High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
24 MDMB-CHMINAC MO-CHMINACA; N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
25 ADAMANTYL-FUBINACA FUB-AKB48; N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.2 Synthetic Cannabinoid
26 MDMB-CHMCZCA methyl (S)-2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid

Reflex Tests
Test Code Test Name
5970B Synthetic Cannabinoids Confirmation 2019 (Qualitative), Blood
5971B Synthetic Cannabinoids Confirmation 2019 (Qualitative), Blood
Specimen Type
Blood
Requested Volume
5 mL
Minimum Volume
2.1 mL
Special Handling
None
Specimen Container
Gray top tube (Sodium Fluoride / Potassium Oxalate), Lavender top tube (EDTA)

Additional Collection Instructions

Transport Temperature
Frozen
Light Protection
Not Required
Rejection Criteria
Received Room Temperature. Received Refrigerated.

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: Not Stable
Refrigerated: 1 day(s)
Frozen (-20 °C): 14 day(s)
1 AMB-FUBINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide AB-FUBINACA High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
2 4-cyano-CUMYL-BINACA 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
3 ADMB-FUBICA ADB-FUBICA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
4 ADMB-FUBINACA ADB-FUBINACA; N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
5 5-fluoro-QU-PINAC 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indazole-3-carboxylic acid; 5-fluoro NPB 22 High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
6 MMB-FUBICA methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
7 5-fluoro-MMB-PINACA 5-fluoro AMB; methyl ester; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.05 Synthetic Cannabinoid
8 4-fluoro-MDMB-BINACA 4-fluoro-MDMB-BUTINACA; methyl (S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
9 5-fluoro-MDMB-PICA methyl ester; N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
10 MMB-FUBINACA FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
11 CUMYL-THPINACA N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
12 MDMB-FUBICA methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
13 5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA 5F-ADB/5F-AEB; methyl ester/ ethyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)-L-valinate; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.2 Synthetic Cannabinoid
14 AMB-CHMINACA AB-CHMINACA; N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
15 MDMB-FUBINACA / EMB-FUBINACA 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate/ethyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
16 NA-FUBIM (1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone; FUB-JWH-018 High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.2 Synthetic Cannabinoid
17 5-fluoro-EDMB-PINACA ethyl (S)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
18 ADMB-CHMINACA ADB-CHMINACA; MAB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
19 MMB-CHMICA methyl (1-(cyclohexylmethyl)-1H-indole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
20 5-fluoro-NA-PIC naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; NM-2201 High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
21 MDMB-CHMICA methyl ester; N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
22 MMB-CHMINACA MA-CHMINACA; methyl (1-(cyclohexylmethyl)-1H-indazole-3-carbonyl)-L-valinate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.2 Synthetic Cannabinoid
23 NA-FUBIC 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 1-naphthalenyl ester; FDU-PB-22 High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 1 Synthetic Cannabinoid
24 MDMB-CHMINAC MO-CHMINACA; N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid
25 ADAMANTYL-FUBINACA FUB-AKB48; N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.2 Synthetic Cannabinoid
26 MDMB-CHMCZCA methyl (S)-2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) ng/mL 0.1 Synthetic Cannabinoid

Interface Map

LOINC® Information

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.